Welcome To The Mannkind HUB On AGORACOM

Edit this title from the Fast Facts Section

Free
Message: Re: Why MNKD may be a lousy investment even if Afrezza is a great drug/device

Tolero deal is probably something they can only get. There is very little interests for drugs in MNKD's pipeline other than Afrezza. The whole company is betting on Afrezza anyway.

Share
New Message
Please login to post a reply